372 related articles for article (PubMed ID: 23862292)
1. Medical mistrust influences black women's level of engagement in BRCA 1/2 genetic counseling and testing.
Sheppard VB; Mays D; LaVeist T; Tercyak KP
J Natl Med Assoc; 2013; 105(1):17-22. PubMed ID: 23862292
[TBL] [Abstract][Full Text] [Related]
2. What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2.
Adams I; Christopher J; Williams KP; Sheppard VB
J Cancer Educ; 2015 Jun; 30(2):344-52. PubMed ID: 25301325
[TBL] [Abstract][Full Text] [Related]
3. Uptake of genetic counseling and multi-gene panel testing among women in the Intermountain West with previous negative BRCA1 and BRCA2 results contacted for updated testing.
Mooney R; Espinel W; Elrick A; Kehoe K; Kohlmann W; Kaphingst KA
J Genet Couns; 2022 Apr; 31(2):470-478. PubMed ID: 34570943
[TBL] [Abstract][Full Text] [Related]
4. Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects.
Tercyak KP; Demarco TA; Mars BD; Peshkin BN
Am J Med Genet A; 2004 Nov; 131(1):36-41. PubMed ID: 15389697
[TBL] [Abstract][Full Text] [Related]
5. Receipt of genetic counseling recommendations among black women at high risk for BRCA mutations.
Thompson HS; Sussner K; Schwartz MD; Edwards T; Forman A; Jandorf L; Brown K; Bovbjerg DH; Valdimarsdottir HB
Genet Test Mol Biomarkers; 2012 Nov; 16(11):1257-62. PubMed ID: 23057569
[TBL] [Abstract][Full Text] [Related]
6. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Armstrong K; Micco E; Carney A; Stopfer J; Putt M
JAMA; 2005 Apr; 293(14):1729-36. PubMed ID: 15827311
[TBL] [Abstract][Full Text] [Related]
7. Early onset breast cancer in a registry-based sample of African-american women: BRCA mutation prevalence, and other personal and system-level clinical characteristics.
Pal T; Bonner D; Kim J; Monteiro AN; Kessler L; Royer R; Narod SA; Vadaparampil ST
Breast J; 2013; 19(2):189-92. PubMed ID: 23320992
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 and BRCA2 risk perceptions among African American women at increased risk for hereditary breast-ovarian cancer.
Kessler L; Domchek S; Stopfer J; Halbert CH
Community Genet; 2008; 11(4):193-200. PubMed ID: 18417966
[TBL] [Abstract][Full Text] [Related]
9. Black and Minority Ethnic women's decision-making for risk reduction strategies after BRCA testing: Use of context and knowledge.
Machirori M; Patch C; Metcalfe A
Eur J Med Genet; 2019 May; 62(5):376-384. PubMed ID: 30550831
[TBL] [Abstract][Full Text] [Related]
10. Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.
Culver JO; Brinkerhoff CD; Clague J; Yang K; Singh KE; Sand SR; Weitzel JN
Clin Genet; 2013 Nov; 84(5):464-72. PubMed ID: 23323793
[TBL] [Abstract][Full Text] [Related]
11. BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.
McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
Am J Med Genet A; 2005 Mar; 133A(2):165-9. PubMed ID: 15633195
[TBL] [Abstract][Full Text] [Related]
12. The influence of acculturation and breast cancer-specific distress on perceived barriers to genetic testing for breast cancer among women of African descent.
Sussner KM; Thompson HS; Jandorf L; Edwards TA; Forman A; Brown K; Kapil-Pair N; Bovbjerg DH; Schwartz MD; Valdimarsdottir HB
Psychooncology; 2009 Sep; 18(9):945-55. PubMed ID: 19090507
[TBL] [Abstract][Full Text] [Related]
13. Impact of Implementing B-RST
Wernke K; Bellcross C; Gabram S; Ali N; Stanislaw C
Clin Breast Cancer; 2019 Aug; 19(4):e547-e555. PubMed ID: 31005475
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
Thompson HS; Valdimarsdottir HB; Duteau-Buck C; Guevarra J; Bovbjerg DH; Richmond-Avellaneda C; Amarel D; Godfrey D; Brown K; Offit K
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1579-85. PubMed ID: 12496047
[TBL] [Abstract][Full Text] [Related]
15. Genetic counseling and testing for breast cancer risk in African Americans.
Halbert CH
LDI Issue Brief; 2006 Sep; 12(1):1-4. PubMed ID: 17302016
[TBL] [Abstract][Full Text] [Related]
16. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
[TBL] [Abstract][Full Text] [Related]
17. Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.
Hull LE; Haas JS; Simon SR
Am J Prev Med; 2018 Feb; 54(2):221-228. PubMed ID: 29241717
[TBL] [Abstract][Full Text] [Related]
18. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.
Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C
Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464
[TBL] [Abstract][Full Text] [Related]
19. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
[TBL] [Abstract][Full Text] [Related]
20. Psychological functioning in African American women at an increased risk of hereditary breast and ovarian cancer.
Halbert Ch; Kessler L; Collier A; Paul Wileyto E; Brewster K; Weathers B
Clin Genet; 2005 Sep; 68(3):222-7. PubMed ID: 16098010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
